Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
Abstract Background Uterine Corpus Endometrial Carcinoma (UCEC) is a highly heterogeneous tumor, and limitations in current diagnostic methods, along with treatment resistance in some patients, pose significant challenges for managing UCEC. The excessive activation of G2/M checkpoint genes is a cruc...
Saved in:
| Main Authors: | Yiming Liu, Yusi Wang, Shu Tan, Xiaochen Shi, Jinglin Wen, Dejia Chen, Yue Zhao, Wenjing Pan, Zhaoyang Jia, Chunru Lu, Ge Lou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03667-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
by: Valentina Brancato, et al.
Published: (2024-12-01) -
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma
by: Ru-Gen Liao, et al.
Published: (2025-01-01) -
MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation
by: Jiaoyun Lu, et al.
Published: (2025-05-01) -
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01) -
Cyclin D2 – a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis
by: Lizhen Wang, et al.
Published: (2025-07-01)